Molly Agraviador PTA

Recommended Articles

• Musician and Wife Hope for Miracle in Her Battle Against Ovarian Cancer

  A couple in Boston are praying for a miracle as they try to find a way to be admitted to the Dana-Farber Institute.A musical love storyRonny Monroe has lived quite the life as a musician, one that many others aspire to. He was coached by the same singing instructor as Chris Cornell, he has been a...

• Is Tonsillitis Contagious?

  What is tonsillitis?Tonsils are two glands located at the back of the throat and can be seen through the mouth. These glands help prevent infections from developing in the body. Tonsillitis happens when the tonsils become inflamed or infected by viruses or bacteria. Tonsillitis is a common...

• New Explanation for How Ovarian Cancer Spreads

  In their latest publication, a team of researchers with the University of California, Riverside and the University of Notre Dame have revealed a new explanation for how ovarian cancer spreads (or metastasizes). The researchers used electron microscopy and live imaging to study the cellular...

• Organizations that Support Parkinson's Disease Patients and their Families

  Parkinson’s disease is a neuromuscular degenerative disorder that robs those afflicted of their motor functions over time. The average age of a Parkinson’s diagnosis is somewhere around the age of sixty, though at times those that are younger can also be diagnosed with the disease. Cases such as...

• How is a Strep Throat Treated?

  The first goal of the treatment for strep throat is the prevention of the acute rheumatic fever. However, the benefits also include preventing suppurative complications, alleviation of strep throat symptoms, limiting the household spread, and also reducing the duration of the disease. Consult with...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...